Ashland Inc. (ASH)
$72.65+2.64%Close
BUYBEAR · day 27
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.3B
- Beta
- 0.40
- Div yield
- 2.30%
- P/E (TTM)
- 63.73
- Short % float
- 11.26%
- Days to cover
- 6.7
- SI change
- +5.0%
- 1W
- +2.37%
- 1M
- +4.28%
- vs SPY 1W
- +2.51%
- vs SPY 1M
- +1.77%
Industry peers
FMP comparable companies · ranked by market cap
- MEOHBUYMethanex Corporation$4.7BBULLQ 14$60.41+2.45%
- SKESELLSkeena Resources Limited$3.8BRECOVERYQ 21$30.47-1.25%
- AVNTSELLAvient Corporation$3.8BBEARQ 7$41.00+1.49%
- KWRBUYQuaker Houghton$2.7BRECOVERYQ 18$157.33+2.47%
- WDFCBUYWD-40 Company$2.7BRECOVERYQ 18$201.50+0.80%
- NGVTBUYIngevity Corporation$2.4BRECOVERYQ 15$70.92+1.46%
- IOSPBUYInnospec Inc.$2.4BBULLQ 11$97.42+1.85%
- CCSELLThe Chemours Company$2.1BBEARQ 5$13.98-1.42%
- MTXSELLMinerals Technologies Inc.$2.0BBEARQ 8$65.11+1.40%
- SIDBUYCompanhia Siderúrgica Nacional$1.6BRECOVERYQ 27$1.23-2.36%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 35
- VALUE
- 0
- GROWTH
- 46
- GARP
- 60
- TYPE
- Dividend Compounder (blended)
Composite of Value · Growth · GARP
ROIC1.7%
REV YoY-
ROE2.8%
EPS YoY-
ROA1.1%
GROSS29
OP7
NET3
[VALUATION]
P/E TTM63.73
P/E FWD19.21
SECTOR PE25.24
INDUSTRY PE28.99
P/B1.79
P/FCF-
EV/EBITDA11.48
EV/EBIT-
PEG1.29
FCF YIELD-
RISK
INT COV-
D/E78.93
ALTMAN Z-
CURR RATIO3.05
ND/EBITDA-
BETA0.40
PAYOUT RATIO > 100% (146.2%)
Company news
FAQ
- What is LOPJLB’s current signal on ASH?
- LOPJLB’s latest quantitative signal on Ashland Inc. (ASH) is BUY in a BEAR regime. Signals are updated daily.
- What market regime is ASH in?
- Ashland Inc. (ASH) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Ashland Inc. (ASH) do?
- Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solu…